Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mycophenolate mofetil in juvenile dermatomyositis: a case series.
Dagher R, Desjonquères M, Duquesne A, Quartier P, Bader-Meunier B, Fischbach M, Guiguonis V, Picherot G, Cimaz R. Dagher R, et al. Rheumatol Int. 2012 Mar;32(3):711-6. doi: 10.1007/s00296-010-1653-5. Epub 2010 Dec 9. Rheumatol Int. 2012. PMID: 21152922
Causes of death in pediatric systemic lupus erythematosus.
Klein A, Cimaz R, Quartier P, Decramer S, Niaudet P, Baudouin V, Belot A, Bader-Meunier B. Klein A, et al. Clin Exp Rheumatol. 2009 May-Jun;27(3):538-9. Clin Exp Rheumatol. 2009. PMID: 19604455 Free article. No abstract available.
[New treatments for idiopathic juvenile arthritis].
Bader-Meunier B, Quartier P. Bader-Meunier B, et al. Arch Pediatr. 2009 Dec;16(12):1607-11. doi: 10.1016/j.arcped.2009.07.020. Epub 2009 Nov 5. Arch Pediatr. 2009. PMID: 19896351 French.
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B, Amoura Z, Ravaud P, Hachulla E, Jouenne R, Combe B, Bonnet C, Cacoub P, Cantagrel A, de Bandt M, Fain O, Fautrel B, Gaudin P, Godeau B, Harlé JR, Hot A, Kahn JE, Lambotte O, Larroche C, Léone J, Meyer O, Pallot-Prades B, Pertuiset E, Quartier P, Schaerverbeke T, Sibilia J, Somogyi A, Soubrier M, Vignon E, Bader-Meunier B, Mariette X, Gottenberg JE; Club Rhumatismes et Inflammation. Terrier B, et al. Arthritis Rheum. 2010 Aug;62(8):2458-66. doi: 10.1002/art.27541. Arthritis Rheum. 2010. PMID: 20506527 Free article.
Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry.
Bader-Meunier B, Decaluwe H, Barnerias C, Gherardi R, Quartier P, Faye A, Guigonis V, Pagnier A, Brochard K, Sibilia J, Gottenberg JE, Bodemer C; Club Rhumatismes et Inflammation. Bader-Meunier B, et al. J Rheumatol. 2011 Jul;38(7):1436-40. doi: 10.3899/jrheum.101321. Epub 2011 Jun 15. J Rheumatol. 2011. PMID: 21677003
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.
Ruperto N, Quartier P, Wulffraat N, Woo P, Ravelli A, Mouy R, Bader-Meunier B, Vastert SJ, Noseda E, D'Ambrosio D, Lecot J, Chakraborty A, Martini A, Chioato A; Paediatric Rheumatology International Clinical Trials Organisation. Ruperto N, et al. Arthritis Rheum. 2012 Feb;64(2):557-67. doi: 10.1002/art.33342. Arthritis Rheum. 2012. PMID: 21953497 Free article. Clinical Trial.
297 results